|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Trade accounts receivable (less allowances of $101 and $90) (Note 4) | ||||||||||||||||||||
| Inventories (Note 5) | ||||||||||||||||||||
| Assets held for sale (Note 2) | ||||||||||||||||||||
| Other current assets (Note 6) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Investments in affiliates | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other non-current assets (Note 7) | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Short-term debt (Note 13) | ||||||||||||||||||||
| Current portion of long-term debt (Note 13) | ||||||||||||||||||||
| Trade accounts payable (includes $926 and $643 carried at fair value) (Note 11) | ||||||||||||||||||||
| Current operating lease obligations | ||||||||||||||||||||
| Liabilities held for sale (Note 2) | ||||||||||||||||||||
| Other current liabilities (Note 10) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (Note 13) | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Non-current operating lease obligations | ||||||||||||||||||||
| Other non-current liabilities (Note 16) | ||||||||||||||||||||
| Redeemable noncontrolling interest | ||||||||||||||||||||
| Equity (Note 17): | ||||||||||||||||||||
| Convertible perpetual preference shares, par value $.01; authorized—21,000,000 shares, issued and outstanding: 2022 —zero shares, 2021—6,899,683 shares (liquidation preference $100 per share) | ||||||||||||||||||||
| Common shares, par value $.01; authorized – 400,000,000 shares; issued and outstanding: 2023 – 146,368,303 shares, 2022 – 149,907,932 shares | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) (Note 17) | ||||||||||||||||||||
| Treasury shares, at cost; 2022—18,835,812 and 2021—16,726,697 shares | ||||||||||||||||||||
| Treasury shares, at cost; 2023 - 23,163,348 shares and 2022 - 18,835,812 shares | ||||||||||||||||||||
| Total Bunge shareholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interest and equity | ||||||||||||||||||||
Loading...